'Practice Changing' Trial for Inoperable Locally Advanced NSCLC EGFR testing now needed for all patients with stage III disease, experts say Jun 02, 2024
Virtual and In-Person Palliative Care Equally Beneficial in Advanced Lung Cancer No differences observed in quality of life metric, patient and caregiver satisfaction Jun 02, 2024
Subcutaneous Amivantamab Plus Lazertinib Non-Inferior to IV Dosing in NSCLC Unexpectedly offers a possible overall survival benefit, researchers say Jun 01, 2024
Novel Bispecific in EGFR-Mutant Lung Cancer Boosts PFS After Targeted Agents China-based trial may present a hurdle to FDA approval, however Jun 01, 2024
Fewer Suicides in Cancer Patients; Circadian Rhythm Boost; HIV Vaccine for Cancer? News, features, and commentary about cancer-related issues May 31, 2024
Unprecedented PFS Results in ALK-Positive Lung Cancer Trial "We have not seen anything close to this," says expert May 31, 2024
Smoking Isn't the Only Source of Nicotine Addiction in Town Emerging data suggest pharmacological interventions may help patients quit vaping May 29, 2024
Ignoring Colonoscopy Advice; Inflamed Tongue, Then Cancer; Acupuncture for Dry Mouth News, features, and commentary about cancer-related issues May 24, 2024
Psychostimulant No Help in Relieving Cancer-Related Fatigue No significant differences in outcomes between methylphenidate, placebo May 22, 2024
Cancer and Intimate-Care Products; Boost for CRC Stool Tests; Biopsy by Ultrasound? News, features, and commentary about cancer-related issues May 17, 2024
FDA OKs Novel BiTE Agent for Small Cell Lung Cancer First-in-class tarlatamab achieved a 40% ORR in previously treated extensive-stage SCLC May 16, 2024
Perioperative Nivolumab Boosts EFS in Resectable Lung Cancer CheckMate 77T trial shows 42% reduction in risk of tumor recurrence, progression, or death May 15, 2024
Will AI Replace Radiologists, or Just Make Them Better Than Ever? Opinions differ on how much physicians should be embracing the technology May 14, 2024
Glecirasib Shows Promising Efficacy in KRAS-Mutated NSCLC Trend towards better response rate, PFS compared with approved KRAS inhibitors May 01, 2024
EPA Bans Consumer Use of Toxic Chemical Known to Cause Liver, Lung Cancers Methylene chloride has killed at least 88 workers since 1980 Apr 30, 2024
White House Indefinitely Delays Plan to Ban Menthol Cigarettes Biden administration has delayed the final rule several times recently Apr 26, 2024
Academics + Pharma = Big Bucks; New CAR-T Warnings; Patients Seek Cancer Tests News, features, and commentary about cancer-related issues Apr 19, 2024
Alectinib Lands FDA Approval for Adjuvant Therapy in NSCLC The ALK inhibitor reduced the risk of recurrence or death by 76% versus chemotherapy Apr 19, 2024
Riding the 'Boob Bus'; Prior Authorization Pushback; Cancer Warning for Alcohol? News, features, and commentary about cancer-related issues Apr 12, 2024
Accelerated Aging Linked to Recent Increase in Early-Onset Solid Tumors Strength of association increased in more recent birth cohorts Apr 09, 2024
Can Late-Stage Cancer Incidence Serve as an Endpoint for Screening Trials? Study shows it may be an alternative to cancer-specific mortality for some cancers, but not all Apr 08, 2024
Enhertu Gets Tumor-Agnostic FDA Approval for HER2-Positive Cancers About half of patients responded, duration of response as long as 19 months in three trials Apr 05, 2024
Cancer 'Tidal Wave' Forecast; Not Decaf, Too! Cautionary Tales of Cancer, Cannabis News, features, and commentary about cancer-related issues Apr 05, 2024
Forget 'Pack-Years' for Lung Cancer Screening Eligibility, Study Suggests Switching to just a 20-year duration of smoking could catch more cancers, eliminate disparities Apr 01, 2024
Chemo and Heart Disease; Flawed Lung Cancer Screening; New Vax Recommendations News, features, and commentary about cancer-related issues Mar 29, 2024
Graphic Images on Cigarettes of Smoking's Harm Are Constitutional, Court Rules Partial victory for federal regulators seeking to toughen warning labels Mar 22, 2024
Broader Cancer Risk With CAR-T? AI for Physician Burnout; 'Lollipops' ID Oral Cancer News, features, and commentary about cancer-related issues Mar 22, 2024
EPA Bans Asbestos, a Deadly Carcinogen Still in Use Decades After Partial Ban New rule would prohibit chrysotile asbestos Mar 19, 2024
First-Line Immunotherapy Alone Sufficient for Older NSCLC Patients, Study Suggests Retrospective analysis finds similar OS, PFS whether or not patients also received chemotherapy Mar 07, 2024
A Blenrep Comeback? Cancer Vaccine for Dogs; U.K. Snubs Enhertu News, features, and commentary about cancer-related issues Mar 07, 2024
FDA OKs Amivantamab as First-Line Lung Cancer Treatment Bispecific drug lands full approval for NSCLCs with EGFR exon 20 insertion mutations Mar 04, 2024
Changing the Surgical Paradigm in Oligometastatic NSCLC Propensity-score matched analysis suggests survival benefit with surgery to the primary tumor Feb 23, 2024
Transforming Shots Into Pills; 'Tip of the Iceberg' for TILs? Food Additives Warning News, features, and commentary about cancer-related issues Feb 23, 2024
Another COVID Toll: Over 134,000 Undiagnosed Cancers During Height of Pandemic Diagnosis rates remained low throughout 2020, with mortality increase projected Feb 22, 2024
Arginine Starvation Boosts OS in Mesothelioma With frontline immunotherapy now standard, strategy could potentially find home in second-line Feb 16, 2024
Perioperative Tislelizumab Demonstrates Survival Benefit in NSCLC But how well will the results from China translate to Western populations? Feb 16, 2024
Rush to Publish? Medicare Drug Plan Lawsuit Quashed; Activity Curbs Cancer Pain News, features, and commentary about cancer-related issues Feb 16, 2024
Tepotinib Gains Full Approval for Metastatic NSCLC Agency converts accelerated approval for subset with MET exon 14 mutations Feb 16, 2024
No Relief From Drug Shortages; New Lymphedema Guideline; A 'Good' Patient No More News, features, and commentary about cancer-related issues Feb 09, 2024
Smokers Who Quit and Stick With It See Greatest Reduction in Cancer Risk Cessation at any age proved helpful for lowering cancer risk Feb 06, 2024
